| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1579 | 2011 |
| Epithelial ovarian cancer: evolution of management in the era of precision medicine S Lheureux, M Braunstein, AM Oza CA: a cancer journal for clinicians 69 (4), 280-304, 2019 | 1383 | 2019 |
| Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011 | 1381 | 2011 |
| Derivation of novel human ground state naive pluripotent stem cells O Gafni, L Weinberger, AAF Mansour, YS Manor, E Chomsky, ... Nature 504 (7479), 282-286, 2013 | 1246 | 2013 |
| Microglia development follows a stepwise program to regulate brain homeostasis O Matcovitch-Natan, DR Winter, A Giladi, S Vargas Aguilar, A Spinrad, ... Science 353 (6301), aad8670, 2016 | 1242 | 2016 |
| Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, ... The lancet oncology 18 (1), 75-87, 2017 | 1233 | 2017 |
| Transcriptional heterogeneity and lineage commitment in myeloid progenitors F Paul, Y Arkin, A Giladi, DA Jaitin, E Kenigsberg, H Keren-Shaul, ... Cell 163 (7), 1663-1677, 2015 | 1216 | 2015 |
| Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses Y Lavin, S Kobayashi, A Leader, ED Amir, N Elefant, C Bigenwald, ... Cell 169 (4), 750-765. e17, 2017 | 1165 | 2017 |
| Disease-associated microglia: a universal immune sensor of neurodegeneration A Deczkowska, H Keren-Shaul, A Weiner, M Colonna, M Schwartz, I Amit Cell 173 (5), 1073-1081, 2018 | 1146 | 2018 |
| Microglia states and nomenclature: A field at its crossroads RC Paolicelli, A Sierra, B Stevens, ME Tremblay, A Aguzzi, B Ajami, I Amit, ... Neuron 110 (21), 3458-3483, 2022 | 1092 | 2022 |
| Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner DA Jaitin, L Adlung, CA Thaiss, A Weiner, B Li, H Descamps, P Lundgren, ... Cell 178 (3), 686-698. e14, 2019 | 1026 | 2019 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 993 | 2021 |
| Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial AM Oza, AD Cook, J Pfisterer, A Embleton, JA Ledermann, ... The Lancet Oncology 16 (8), 928-936, 2015 | 987 | 2015 |
| Single-cell spatial reconstruction reveals global division of labour in the mammalian liver KB Halpern, R Shenhav, O Matcovitch-Natan, B Tóth, D Lemze, M Golan, ... Nature 542 (7641), 352-356, 2017 | 981 | 2017 |
| Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma H Li, AM van der Leun, I Yofe, Y Lubling, D Gelbard-Solodkin, ... Cell 176 (4), 775-789. e18, 2019 | 973 | 2019 |
| Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling M Levy, CA Thaiss, D Zeevi, L Dohnalová, G Zilberman-Schapira, ... Cell 163 (6), 1428-1443, 2015 | 967 | 2015 |
| Chromatin state dynamics during blood formation D Lara-Astiaso, A Weiner, E Lorenzo-Vivas, I Zaretsky, DA Jaitin, E David, ... science 345 (6199), 943-949, 2014 | 853 | 2014 |
| Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil … ML Rothenberg, AM Oza, RH Bigelow, JD Berlin, JL Marshall, ... Journal of Clinical Oncology 21 (11), 2059-2069, 2003 | 851 | 2003 |
| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ... Cell 182 (6), 1401-1418. e18, 2020 | 831 | 2020 |
| Microbiota diurnal rhythmicity programs host transcriptome oscillations CA Thaiss, M Levy, T Korem, L Dohnalová, H Shapiro, DA Jaitin, E David, ... Cell 167 (6), 1495-1510. e12, 2016 | 806 | 2016 |
